scieee Open visual document viewer

Properties of taurine release in glucose-free media in hippocampal slices from developing and adult mice

Oja, Simo,Saransaari, Pirjo

Abstract

This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Full text

Resea ch A icle P ope ies o Tau ine Release in Glucose-F ee Media in Hippocampal Slices om De eloping and Adul Mice Simo S. Oja and Pi jo Sa ansaa i Medical School, 33014 Uni e si y o Tampe e, Finland Co espondence should be add essed o Simo S. Oja; simo.o[email p o ec ed] Recei ed 14 May 2015; Accep ed 21 July 2015 Academic Edi o : Ha i Shanke Sha ma Copy igh © 2015 S. S. Oja and P. Sa ansaa i. This is an open access a icle dis ibu ed unde he C ea i e Commons A ibu ion License, which pe mi s un es ic ed use, dis ibu ion, and ep oduc ion in any medium, p o ided he o iginal wo k is p ope ly ci ed. The elease o p eloaded [3H] au ine om hippocampal slices om de eloping 7-day-old and young adul 3-mon h-old mice was s udied in a supe usion sys em in he absence o glucose. These hypoglycemic condi ions enhanced he elease a bo h ages, he e ec being ma kedly g ea e in de eloping mice. A depola izing K+concen a ion accen ua ed he elease, which indica es ha i was pa ially media ed by exocy osis. The anion channel blocke s we e inhibi o y, wi nessing he con ibu ion o ion channels. NO- gene a ing agen s omen ed he elease as a sign o he pa icipa ion o exci a o y amino acid ecep o s. The o he second messenge sys ems we e appa en ly less e icien . The much g ea e au ine elease could be a eason o he well-known g ea e ole ance o de elopingne ous issue olacko glucose. 1. In oduc ion Hypoglycemia is a me abolic condi ion common du ing de elopmen and may lead o se e e neu ological de ec s in human in an s. Howe e , he e ec s o hypoglycemia on he de eloping b ain a e s ill incomple ely unde s ood [1]. The b ain de i es mos o i s ene gy om he oxida ion o glucose, bu du ing de elopmen i also has an abili y o u ilize al e na i e ene gy subs a es which may o e p o ec ion du ing hypoglycemia [2, 3]. On he o he hand, poo ese es o high-ene gy phospha es and a high me abolic a e may p edispose he de eloping b ain o hypoglycemic inju y [4, 5]. In he b ain he hippocampus is he egion mos sensi i e o lack o oxygen and glucose. Ene gy dep i a ion leads o neu onal cell dea h, caused p ima ily by exci o oxici y due o excessi e glu ama e elease [6, 7]. Tau ine (2-aminoe hanesul onic acid) is p esen a high concen a ions in he b ain. Du ing on ogenic de elopmen i s concen a ion e en exceeds ha o he main exci a o y ansmi e glu ama e [8]. I inc eases memb ane chlo ide conduc ance, causing hype pola iza ion and inhibi ing neu- onal i ing [9, 10]. Tau ine also a enua es he excessi e neu onal accumula ion o Ca2+,whichp edisposescells o damage [11] and p e en s o educes he glu ama e- induced ele a ion o in acellula Ca2+ [12] by inhibi ing he glu ama e-induced elease o Ca2+ om he in e nal pools [13] and he glu ama e-induced Ca2+ in lux h ough L-, P/Q-, and N- ypes o ol age-ga ed Ca2+ channels [14]. Tau ine hus egula es cy oplasmic and mi ochond ial calcium homeos a- sis [15] and in his manne p o ec s neu al cells agains he oxici y o exci a o y amino acids in he hippocampus [16]. Cell-damaging condi ions, including hypoglycemia, inc ease he elease o au ine [17, 18] oge he wi h ha o exci a o y amino acid neu o ansmi e s. Ou p ima y assump ion is ha au ine elease in he absence o an adequa e supply o glucose could p o ec neu al cells om inju y. In he p esen s udy we he e o e examined he gene al p ope ies o au ine eleasein hehippocampusinhypoglycemiaandhow he eleaseisa ec edbyionchannels,secondmessenge sys ems, and adenosine ecep o s. 2. Ma e ials and Me hods 2.1. Ma e ials. De eloping (7-day-old) and young adul (3- mon h-old) NMRI mice o bo h sexes we e used in he Hindawi Publishing Co po a ion Jou nal o Amino Acids Volume 2015, A icle ID 254583, 7 pages h p://dx.doi.o g/10.1155/2015/254583 2Jou nal o Amino Acids expe imen s. All e o s we e made o minimize bo h he su e ing and he numbe o he animals used. The expe - imen s con o med o he Eu opean Communi y Di ec i e (86/609/EEC) o e hical use o expe imen al animals and we e app o ed by he Commi ee o Tampe e Uni e si y o animal expe imen s. [3H]Tau ine (speci ic adioac i i y 1.15 PBq/mol) was ob ained om Ame sham In e na ional, B is ol, UK. The a ious e ec o s we e pu chased om he Toc is Bioscience (B is ol, UK) o Sigma Ald ich (S . Louis, MO). 2.2. Release Expe imen s. Co onal slices 0.4 mm hick weigh- ing 15–20 mg we e manually p epa ed om he mouse hip- pocampus wi h a issue slice o S adie-Riggs ype. The slices we e immedia ely imme sed in 5 mL o oxygena ed medium and incuba ed wi h 0.01 mM [3H] au ine (50 MBq/L) a 37∘C o 30 min unde agi a ion. The s anda d K ebs-Ringe - Hepes medium con ained (in mmol/L) NaCl 127, KCl 5, CaCl2 0.8, MgSO41.3, Na2HPO41.3, N-2-hyd oxye hylpipe azine- N󸀠-2-e hanesulphonic acid (Hepes) 15, NaOH 11, and D- glucose10(pH7.4).Thesliceswe e hen ans e edin o 0.25 mL cups and supe used wi h he abo e medium a a a e o 0.25 mL/min o 50 min in a sys em in which eely loa ing shaken slices we e kep unde a con inuous low o oxygen in o de o p ese e hei iabili y [19]. Hypo- glycemic condi ions we e induced by omi ing glucose om he supe usion media. Po assium s imula ion was applied om 30 o 50 min wi h 50 mM K+. In ou expe imen al se up his K+concen a ion has yielded he bes and mos ep oducible esponses in GABA and au ine elease [19]. This high K+concen a ion may cause elease no only om neu ons bu om glial cells as well [20]. Howe e , au ine elease is ypically slow a onse and p olonged and high K+concen a ions abo e hose p e ailing in i o should be used in in i o expe imen s [21]. The di e en e ec o s we e added o he medium a he onse o supe usions, as explained in he able legends. The supe usion medium was pooled du ing he i s 20min, whe ea e 2min ac ions (0.5 mL) we e collec ed di ec ly in o small scin illa ion ials wi h a ac ion collec o . A e supe usion he slices we e weighed, homogenized in ice-cold 5% (w/ ) ichlo oace ic acid solu ion, and cen i uged, and he clea supe na an s we e used o scin illa ion coun ing. The e luen samples we esubjec ed o hesameanalyses. 2.3. Es ima ion o E lux Ra e Cons an s. Desa u a ion cu es o labeled au ine om he slices we e plo ed as a unc ion o ime on he basis o he adioac i i ies emaining in heslicesa e supe usionand eco e edin hecollec ed supe usa e ac ions [19]. Du ing supe usion he elease o labeled au ine o igina es ini ially om he ex acellula spaces in slices. This sou ce is g adually exhaus ed du ing he i s 20minand he eleasesubsequen lyoccu s om he in acellula pools. The e lux a e cons an s o au ine o he ime in e als o 20 o 30 min (𝑘1,ini ial eleasephase)and 34–50 min (𝑘2,la e eleasephase)we ecompu edasnega i e slopes o he eg essionlineso heloga i hmo adioac i i y emaining in he slices e sus supe usion ime. The e we e no di e ences be ween he esul s om male and emale mice and he esul s om bo h sexes we e he e o e combined. 2.4. S a is ical Analysis. The signi icance o he esul s was analyzed wi h wo-way analysis o a iance (ANOVA) using SPSS s a is ics, e sion 17.0, compu e p og am. The analyses we e done by g ouping he esul s acco ding o he na u e o hee ec o ss udied,po assiums imula ion,chlo idechannel blocke s, NO-gene a ing agen s, adenosine agonis s, and second messenge s. When signi ican e ec s we e de ec ed, he pos hoc Bon e oni es was applied o b ing ou he di e ences be ween he sample means. They we e conside ed signi ican when he calcula ed 𝑝 alues we e less han 0.05 o 0.01. 3. Resul s Hypoglycemia signi ican ly enhanced au ine elease in bo h age g oups. In adul 3-mon h-old mice he ac ional elease a e cons an in he p esence o glucose in medium was o he supe usion pe iod o 34–50 min (1.54±0.04)×10−3 (𝑛=18) andin heabsenceo glucose(1.93 ± 0.18)×10−3,𝑛=11, signi ican ly di e en a a le el o p= 0.042. The hypoglycemia e ec was mo e ma ked in 7-day-old mice, he co esponding cons an s being (0.38±0.20)×10−3,𝑛=11,and(1.20±0.12) ×10−3,𝑛=11,p= 0.000, espec i ely. S imula ion by 50 mM K+enhanced he eleasein heabsenceo glucose(d =3, 𝐹 = 23.007,𝑝 = 0.000). The enhancemen s we e 60 pe cen and 63 pe cen in adul (𝑝 = 0.000) and de eloping (𝑝= 0.001) mice, espec i ely (see Table 1). The anion channel blocke s gene ally inhibi ed he elease (d =7,𝐹 = 13.562,𝑝 = 0.000). O hem, DIDS signi ican ly inhibi ed he K+-s imula ed au ine eleaseinbo hadul (𝑝 = 0.013) and de eloping (𝑝 = 0.044) mice, being in adul micealsoe ec i eon heuns imula ed elease(𝑝= 0.047) (Table 1). SITS, he blocke o chlo ide anspo , was e en mo e e ec i e in all expe imen al si ua ions (in adul mice, uns imula ed elease 𝑝 = 0.11,s imula ed elease, 𝑝 = 0.035, and in de eloping mice he co esponding da a 𝑝 = 0.016 and 𝑝 = 0.017). Ano he anspo inhibi o 9-AC was no e ec i e. All ni ic oxide gene a o s, SNAP, SNP, and hyd oxylamine, we e s ong s imula o s in au ine elease in bo h adul (d =7,𝐹 = 32.190,𝑝 = 0.000)and de eloping (d =7,𝐹 = 13.732,𝑝 = 0.000) mice and in bo h heuns imula edandK +-s imula ed elease (Table 2). On he o he hand, all adenosine ecep o agonis s es ed, CHA, R- PIA and CGS 21680, and iluzole, which inhibi s glu ama e elease and GABA up ake, we e wi hou any e ec s (Table 3). O compounds in ol ed in he second messenge sys- ems, genis ein, wi h i s main known ac i i y as a y osine kinase inhibi o , was no e ec i e du ing he pe iod o 34– 50 (Table 4), whe eas quinac ine, a nonselec i e inhibi o o bo h monoamine oxidases A and B, inhibi ed he uns im- ula ed and K+-s imula ed elease in bo h age g oups a all s ages o supe usion (d =6,𝐹 = 23.648,𝑝 = 0.000). The p o ein kinase C ac i a o PMA only inhibi ed he uns imula ed eleaseinadul mice(𝑝 = 0.036), whe eas he p o ein kinase inhibi o chele y h ine was no e ec i e. Jou nal o Amino Acids 3 Table 1: E ec s o ion channel inhibi o s on au ine elease om hippocampal slices om 3-mon h-old and 7-day-old mice in hypoglycemia. E ec o s E lux a e cons an s (×10−3min−1)±SEM 3-mon h-old 7-day-old 𝑘1𝑘2𝑘1𝑘2 Basal (con ol) 2.36 ±0.11 (20) 1.93 ±0.18 (11) 1.34 ±0.08 (31) 1.20 ±0.11 (11) +50 mM K+(con ol) 2.92 ±0.21 (10) 1.90 ±0.10 (12) DIDS 0.5 mM 1.34 ±0.15∗∗ (6) 1.31 ±0.10∗(4) 1.12 ±0.14 (8) 1.16 ±0.13 (4) +50 mM K+1.81 ±0.12∗∗ (4) 1.45 ±0.06∗(4) SITS 2.0 mM 1.04 ±0.07∗∗ (8) 0.93 ±0.06∗∗ (4) 0.80 ±0.09∗∗ (6) 0.62 ±0.06∗∗ (4) +50 mM K+1.50 ±0.21∗∗ (4) 0.90 ±0.12∗∗ (4) 9-AC 0.2 mM 2.67 ±0.17 (5) 2.74 ±0.49 (4) 1.82 ±0.23 (8) 1.07 ±0.09 (4) +50 mM K+3.53 ±0.32 (4) 1.84 ±0.10 (4) The d ugs we e added a he beginning o supe usion and 50 mM K+a 30 min. The esul s show he e lux a e cons an s ±SEM (×10−3min−1) o he ime in e als o 20–30 min (𝑘1) and 34–50 min wi hou he excess o K+o in he p esence o 50 mM K+(𝑘2) wi h he numbe o independen expe imen s in pa en hesis. Abb e ia ions: DIDS, diiso hiocyanos ilbene-2󸀠2-disulphona e; SITS, 4-ace amido-4󸀠-iso hiocyanos ilbene-2󸀠2-disulphona e; 9- AC, 9-an h aceneca boxylic acid. Signi icance o di e ences om he co esponding con ols: ∗𝑝 < 0.05,∗∗𝑝 < 0.01. Table 2: E ec s o ni ic oxide gene a o s on au ine elease om hippocampal slices om 3-mon h-old and 7-day-old mice in hypoglycemia. E ec o s E lux a e cons an s (×10−3 min−1)±SEM 3-mon h-old 7-day-old 𝑘1𝑘2𝑘1𝑘2 Basal (con ol) 2.36 ±0.11 (20) 1.93 ±0.18 (11) 1.34 ±0.08 (31) 1.20 ±0.11 (11) +50 mM K+(con ol) 2.92 ±0.21 (10) 1.90 ±0.10 (12) SNAP 1.0 mM 4.31 ±0.22∗∗ (7) 5.44 ±0.14∗∗ (4) 2.84 ±0.11∗∗ (8) 2.17 ±0.07∗∗ (4) +50 mM K+5.35 ±0.15∗∗ (4) 2.34 ±0.08∗∗ (4) SNP 1.0 mM 3.17 ±0.13∗∗ (15) 4.23 ±0.38∗∗ (8) 1.80 ±0.21∗(7) 1.65 ±0.13∗(4) +50 mM K+4.41 ±0.77∗∗ (4) 1.98 ±0.10∗∗ (4) Hyd oxylamine 5.0 mM 5.16 ±0.17∗∗ (7) 6.04 ±0.76∗∗ (7) 3.82 ±0.33∗∗ (8) 3.44 ±0.16∗∗ (4) +50 mM K+7. 03 ±0.28∗∗ (4) 3.84 ±0.10∗∗ (4) The e ec o s we e added a he beginning o supe usion and 50 mM K+a 30 min. The esul s show he e lux a e cons an s ±SEM (×10−3 min−1) o he ime in e als o 20–30 min (𝑘1) and 34–50 min wi hou he excess o K+o in he p esence o 50 mM K+(𝑘2) wi h he numbe o independen expe imen s in pa en hesis. SNAP: S-ni oso-N-ace ylpenicillamine; SNP: sodium ni op usside. Signi icance o di e ences om he co esponding con ols: ∗𝑝 < 0.05, ∗∗𝑝 < 0.01. Table 3: E ec s o adenosine agonis s and iluzole on au ine elease om hippocampal slices om 3-mon h-old and 7-day-old mice in hypoglycemia. E ec o s E lux a e cons an s (×10−3 min−1)±SEM 3-mon h-old 7-day-old 𝑘1𝑘2𝑘1𝑘2 Basal (con ol) 2.36 ±0.11 (20) 1.93 ±0.18 (11) 1.34 ±0.08 (31) 1.20 ±0.11 (11) +50 mM K+(con ol) 2.92 ±0.21 (10) 1.90 ±0.10 (12) CHA 0.5 mM 2.98 ±0.12 (6) 1.85 ±0.30 (6) 1.48 ±0.07 (10) 1.11 ±0.06 (7) +50 mM K+2.42 ±0.27 (4) 2.00 ±0.06 (4) R-PIA 0.1 mM 2.46 ±0.17 (6) 1.92 ±0.21 (6) 1.97 ±0.19 (6) 1.41 ±0.12 (4) +50 mM K+3.63 ±0.51 (4) 2.12 ±0.11 (4) CGS 21680 10.0 mM 2.59 ±0.22 (4) 2.20 ±0.20 (4) 1.75 ±0.16 (6) 1.38 ±0.20 (4) +50 mM K+3.44 ±0.32 (4) 2.28 ±0.11 (4) Riluzole 0.1 mM 2.47 ±0.17 (7) 1.86 ±0.27 (4) 1.86 ±0.15∗(6) 1.38 ±0.10 (4) +50 mM K+2.50 ±0.35 (4) 2.23 ±0.15 (4) The agonis s we e added a he beginning o supe usion and 50 mM K+a 30 min. The esul s show he e lux a e cons an s ±SEM (×10−3 min−1) o he ime in e als o 20–30 min (𝑘1) and 34–50 min wi hou he excess o K+o in he p esence o 50 mM K+(𝑘2) wi h he numbe o independen expe imen s in pa en hesis. CHA: N6-cyclohexyladenosine; R-PIA: (R(−)N6-(2-phenylisop opyl)adenosine; CGS 21680: 4-[2-[[6-amino-9-(N-e hyl-𝛽-D- ibo u anu onamidosyl)-9H-pu in-2-yl]amino]e hyl]benzenep opanoic acid hyd ochlo ide. Signi ican di e ence om he con ol: ∗𝑝 < 0.05. 4Jou nal o Amino Acids Table 4: E ec s o compounds in ol ed in he second messenge sys ems on au ine elease om mouse hippocampal slices in hypoxia. Concen a ion (mM) E lux a e cons an s (×10−3 min−1)±SEM 3-mon h-old 7-day-old 𝑘1𝑘2𝑘1𝑘2 Basal (con ol) 2.36 ±0.11 (20) 1.93 ±0.18 (11) 1.34 ±0.08 (31) 1.20 ±0.11 (11) +50 mM K+(con ol) 2.92 ±0.21 (10) 1.90 ±0.10 (12) Genis ein 0.001 2.59 ±0.13 (7) 2.06 ±0.18 (7) 1.92 ±0.16∗(7) 1.44 ±0.16 (4) +50 mM K+3.07 ±0.25 (4) 2.27 ±0.06 (4) Quinac ine 0.01 1.20 ±0.08∗∗ (7) 0.83 ±0.05∗∗ (4) 0.75 ±0.07∗∗ (8) 0.61 ±0.06∗∗ (4) +50 mM K+1.12 ±0.13∗∗ (4) 0.79 ±0.05∗∗ (4) PMA 0.00001 2.31 ±0.20 (8) 1.77 ±0.11 (4) 1.80 ±0.15∗(8) 1.33 ±0.17 (4) +50 mM K+1.95 ±0.17∗(4) 1.85 ±0.03 (4) Chele y h ine 0.001 2.49 ±0.17 (7) 2.07 ±0.14 (4) 1.73 ±0.18 (8) 1.53 ±0.04 (4) +50 mM K+3.40 ±0.51 (4) 2.01 ±0.09 (4) IBMX 1.0 1.85 ±0.16 (8) 2.51 ±0.29 (4) 1.99 ±0.24 (6) 1.33 ±0.11 (4) +50 mM K+2.70 ±0.13 (4) 1.85 ±0.03 (4) RO 20-1724 0.2 3.46 ±0.12∗∗ (8) 3.43 ±0.15∗∗ (4) 1.96 ±0.26 (7) 1.27 ±0.17 (4) +50 mM K+4.56 ±0.30∗∗ (4) 2.65 ±0.33∗(4) Zap inas 0.1 2.31 ±0.15 (8) 2.00 ±0.20 (8) 1.00 ±0.13 (6) 0.66 ±0.12∗(4) +50 mM K+2.53 ±0.06 (4) 2.04 ±0.23 (4) ODQ 0.01 2.51 ±0.18 (7) 2.01 ±0.13 (4) 1.50 ±0.17 (8) 1.19 ±0.08 (8) +50 mM K+2.50 ±0.25 (4) 2.04 ±0.06 (4) Alloxan 5.0 2.81 ±0.31 (7) 2.19 ±0.06 (4) 1.70 ±0.17 (6) 1.58 ±0.25 (4) +50 mM K+3.13 ±0.10 (4) 1.86 ±0.07 (4) The agonis s we e added a he beginning o he supe usion and 50 mM K+a 30 min. The esul s show he e lux a e cons an s ±SEM (×10−3 min−1) o he ime in e als o 20–30 min (𝑘1)and o 34–50minwi hou heexcesso K +o in he p esence o 50 mM K+(𝑘2) wi h he numbe o independen expe imen s in pa en hesis. PMA: 4𝛽-pho bol 12-my is a e 13-ace a e; IBMX: 3-isobu yl-1-me hylxan hine; ODQ: 1H-[1,2,4]oxadiazolo[4,3]quinoxalin-1-one; RO 20-1724: 4-(3-bu oxy-4-me hoxyphenyl)-2-imidazolidone. Signi icance o di e ences om he co esponding con ols: ∗𝑝 < 0.05,∗∗𝑝 < 0.01. The nonspeci ic inhibi o o cAMP and cGMP phosphodi- es e ases and he nonselec i e adenosine ecep o an agonis IBMX was no e ec i e du ing he pe iod o 34–50 min. The selec i e inhibi o o cGMP-insensi i e phosphodies e ase, ype IV, RO 20-1724 enhanced bo h he uns imula ed (𝑝= 0.008)ands imula ed(𝑝 = 0.005) elease in adul mice and alsosligh ly hes imula ed elease(𝑝 = 0.038)inde eloping mice (Table 4). The selec i e inhibi o o cGMP-speci ic phosphodies e ases V and VI (PDE5/6) and he agonis a he G p o ein-coupled ecep o 35 zap inas signi ican ly (𝑝= 0.035) educed he uns imula ed elease in 7-day-old mice, whe eas ODQ, he po en and selec i e inhibi o o NO- sensi i e guanylyl cyclase, was wi hou e ec . Alloxan, he unspeci ic inhibi o o adenylyl cyclases, was likewise no e ec i e du ing he pe iod o 34–50 min. 4. Discussion The p esen esul s show au ine elease o be enhanced in hypoxia a bo h ages s udied, he e ec being mo e p onounced in he de eloping hippocampus. The elease is la gelymedia edbyanionchannels,since heanionchannel inhibi o s ma kedly educed i . The ni ic acid gene a o s s ongly s imula ed he elease. The e ec s o he second messenge sys em we e mo e a iable. These ac ions we e also in many cases di e en in adul and de eloping mice. The enhancemen could be due o se e al mechanisms, including Ca2+-dependen exocy osis, Ca2+-independen elease ia e e sal o ca ie -media ed up ake, indisc im- ina e opening o ion channels which allow he passage o au ine molecules, o leakage h ough damaged plasma memb anes. Depola iza ion by K+-s imula ion was now able o u he po en ia e au ine elease a bo h ages unde hypoglycemia. This may signi y elease ia exocy osis, which is also p ese ed in hippocampal slices when hey a e exposed o e en mo e d as ic cell-damaging condi ions such as ischemia ( he absence o glucose and oxygen a mosphe e) [17, 18]. In de eloping mice au ine elease in he absence o glucose is app oxima ely he same as in he p esence o ni ogen a mosphe e wi hou glucose, whe eas in adul s hese ischemic condi ions ha e had e en mo e impac [18]. Bo h neu ons and glial cells ha e been shown o con ain au ine [22], and hus only a pa o he eleased au ine may o igina e om neu ons. K+s imula ion o au ine elease has also been shown o be associa ed wi h cell swelling [23]. Indeed, he olume- egula ed anion channels may con ibu e, oge he wi h he e e sed unc ion o as ocy ic glu ama e anspo e s,up o80pe cen o he o al eleaseo au ine and exci a o y amino acids in global ce eb al ischemia in a s [24]. In acellula swelling ac i a es s e ch-sensi i e ( olume- egula ed) ion channels and is accompanied by he elease Jou nal o Amino Acids 5 o bo h ino ganic and o ganic osmoly es, including au ine [25]. Fo ins ance, he olume- egula ed anion channels ha e been shown o be he p edominan con ibu o s o he elease o exci a o y amino acids in he ischemic co ical penum- b a [26]. The swelling-induced inc ease in au ine elease is a di usional p ocess wi hou any ca ie in ol emen [27]. In bo h he de eloping and adul hippocampus he p esy- nap ically ac ing iono opic glu ama e agonis s signi ican ly inc ease he elease o au ine in a ecep o -media ed manne [28, 29]. Fo ins ance, o he iono opic ecep o s, NMDA ecep o ac i a ion in pa icula has been assumed o play a cen al ole in hypoglycemia-induced glu ama e elease [30]. Ac i a ion o NMDA ecep o s allows Ca2+ o en e he cells. NO syn hase is a Ca2+-dependen enzyme [31], being ac i a ed in he p esence o Ca2+ and henp oducing NO.NOs imula essolubleguanyla ecyclaseandin his manne omen s he p oduc ion o 3󸀠,5󸀠-cyclic guanosine monophospha e [32], which enhances au ine elease [33]. The p esen ac i a o y e ec o he NO gene a o s s udied is in conce wi h his sequence o e en s. NO also egula es neu onal ac i i y by ac i a ing calcium-dependen po assium channels [34, 35]. NO can be he endogenous opene o leak K+channels in he hippocampus as shown in basal o eb ain choline gic neu ons [36]. The inc ease in ex acellula K+ enhances au ine elease. The NO dono s did no ma kedly omen he K+-e oked elease now. The e ec was appa en ly al eady maximal a he K+concen a ion used in his s udy. NO p oduced by an exogenous NO dono has been shown o block bo h e odo oxin-sensi i e and e odo oxin- esis an Na+cu en s in ba o ecep o neu ons [37] and NO o block di e en Na+channels in ba o ecep o neu- ons [38]. In con as , NO dono s SNP and SNAP ha e signi ican ly inc eased he mean pe sis en cu en in excised inside-ou pa ches om cul u ed hippocampal neu ons [39]. Such esul s sugges ha , depending on cell ype, NO may modula e Na+cu en s di e en ly. Tau ine e lux has been shown o be dependen on he p esence o bo h Na+and Cl−ions [40]. The educ ion o elease by he Cl−channel an agonis s SITS and DIDS indica es ha he elease may also occu h ough anion channels, simila o he olume- sensi i e au ine elease in as ocy es and neu ons [41, 42]. The p esen a enua ing e ec o quinac ine on he elease is u he mo e in line wi h his assump ion since quinac ine has been shown o inhibi he hypo onically induced whole cell Cl−cu en s in human submandibula gland (HSG) cells [43]. The a ious second messenge s exe ed less p onounced e ec s on au ine elease. In keeping wi h his he e ec s o di e en me abo opic glu ama e ecep o agonis s and an agonis s ha e also no been pa icula ly e ec i e in au ine elease in he hippocampus [44]. The p esynap ic adenosine ecep o s, pa icula ly o he A1class, a e known o egula e neu o ansmi e elease [45]. The A1 ecep o s ha e also enhanced au ine elease in he adul hippocampus, bu only when i was subjec ed o K+s imula ion in ischemia [46]. In he p esen s udy he nonspeci ic an agonis o adenosine ecep o s likewise exhibi ed only mino e ec s. 5. Conclusions The elease o au ine in he hypoglycemic hippocampus o bo h young and adul mice appea s o be a complex p ocess media ed by se e al di e en mechanisms, such as exocy osis, ca ie e e sal, di usion ia ion channels, and p obably leakage h ough pa ially damaged cell memb anes. Hypoglycemia also e okes he elease o exci a o y amino acids [6, 18]. Glu ama e elease o e ac i a es i s ecep o s and unc ions as an exci o oxic agen . The e is a a ionale he e in ha he ac i a ion o exci a o y amino acid ecep o s causes a concomi an inc ease in au ine elease. Tau ine is inhibi o y in na u e and coun e ac s his excessi e exci a ion. In he de eloping b ain au ine elease is much la ge in magni ude han in he adul b ain, which could be a eason o he well- knowng ea e ole anceo de elopingne ous issue olack o glucose. Abb e ia ions 9-AC: 9-An aceneca boxyla e AIDA: (RS)-1-Aminoindan-1,5- dica boxyla e AMPA: 2-Amino-3-hyd oxy-5-me hyl-4- isoxazolep opiona e 2R,4R-APDC: (2R,4R)-4-Aminopy olidine-2,4- dica boxyla e cAMP: Cyclic adenosine monophospha e ATPase: Adenosine iphospha ase cGMP: Cyclic guanosine monophospha e CGS 21680: 4-[2-[[6-Amino-9-(N-e hyl-𝛽-D- ibo u anu onamidosyl)-9H- pu in-2- yl]amino]e hyl]benzenep opanoic acid hyd ochlo ide CHA: N6-Cyclohexyladenosine DHPG: (S)-3,5-Dihyd oxyphenylglycine DIDS: Diiso hiocyanos ilbene-2,2󸀠- disulphona e DMPX: 3,7-Dime hyl-1-p opa gylxan hine EDTA: E hylenediamine e aace a e EGLU: (2S)-2-Cyclop opyl-4- phosphonophenylglycine GABA: 𝛾-Aminobu y a e GAT: GABA anspo e HA: Hyd oxylamine Hepes: N-2-Hyd oxye hylpipe azine-N󸀠- 2-e hanesulphonic acid IBMX: 3-Isobu yl-1-me hylxan hine L-AP4: L(+)-2-Amino-4- phosphonobu y a e L-NAME: N6-Ni o-L-a ginineme hyles e L-SOP: O-Phospho-L-se ine MK-801 (dizocilpine): (5S,10R)-(+)-Me hyl-10,11- dihyd o-5H- dibenzo(a,d)cyclohep en-5,10- amine 6Jou nal o Amino Acids NBQX: 2,3-Dioxo-6-ni o-1,2,3,4- e ahyd obenzo[ ]quinoxaline-7- sul onamide NMDA: N-Me hyl-D-aspa a e ODQ: 1H-(1,2,4)Oxadiazolo(4,3-a)quinoxalin-1- one PDE: Phosphodies e ase PMA: 4𝛽-Pho bol 12-my is a e 13-ace a e PKC: P o einkinaseC RO 20-1724: 4-(3-Bu oxy-4-me hoxyphenyl)-2- imidazolidone R-PIA: R(−)N6-(2-Phenylisop opyl)adenosine SITS: 4-Ace amido-4󸀠-iso hiocyanos ilbene- 2,2󸀠-disulphona e SNAP: S-Ni oso-N-ace ylpenicillamine SNP: Sodium ni op usside. Con lic o In e es s The au ho s decla e ha he e is no con lic o in e es s ega ding he publica ion o his pape . Acknowledgmen s The skill ul echnical assis ance o M s. I ma Ran amaa and he in aluable help o D . Saka i Oja in s a is ical analyses a e g a e ully acknowledged. Re e ences [1] M. Co nbla h, J. M. Hawdon, A. F. Williams e al., “Con o e - sies ega ding de ini ion o neona al hypoglycemia: sugges ed ope a ional h esholds,” Pedia ics, ol.105,no.5,pp.1141–1145, 2000. [2] A. Nehlig and A. P. de Vasconcelos, “Glucose and ke one body u iliza ion by he b ain o neona al a s,” P og ess in Neu obiology, ol.40,no.2,pp.163–221,1993. [3] R. C. Vannucci and S. J. Vannucci, “Hypoglycemic b ain inju y,” Semina s in Neu obiology, ol.6,pp.73–79,2001. [4] J. E. McGowan and J. M. Pe lman, “Glucose managemen du ing and a e in ensi e deli e y oom esusci a ion,” Clinics in Pe ina ology, ol.33,no.1,pp.183–196,2006. [5]C.M.Bu ns,M.A.Ru he o d,J.P.Boa dman,andF.M. Cowan, “Pa e ns o ce eb al inju y and neu ode elopmen al ou comes a e symp oma ic neona al hypoglycemia,” Pedi- a ics, ol.122,no.1,pp.65–74,2008. [6] M. Sza kowski and D. A well, “T igge ing and execu ion o neu onal dea h in b ain ischaemia: wo phases o glu ama e elease by di e en mechanisms,” T ends in Neu osciences, ol. 17,no.9,pp.359–365,1994. [7] J.-M. Lee, G. J. Zip el, and D. W. Choi, “The changing landscape o ischaemic b ain inju y mechanisms,” Na u e, ol.399,pp.A7– A14, 1999. [8] P. Sa ansaa i and S. S. Oja, “Tau ine and neu al cell damage,” Amino Acids, ol.19,no.3-4,pp.509–526,2000. [9]S.S.Oja,P.Kon o,andP.L ¨ ahdesm¨ aki, “Amino acids as inhibi o y neu o ansmi e s,” P og ess in Pha macology, ol.1, no. 3, pp. 1–119, 1977. [10] S. Oja, E. R. Ko pi, and P. Sa ansaa i, “Iodi ica ion o chlo ide lux ac oss b ain memb anes by inhibi o y amino acids in de eloping and adul mice,” Neu ochemical Resea ch, ol.15,no. 8, pp. 797–804, 1990. [11] P. Kon o and S. S. Oja, “E ec s o au ine on he in lux and e lux o calcium in b ain slices o adul and de eloping mice,” In e na ional Jou nal o Neu oscience, ol.38,no.1-2,pp.103– 109, 1988. [12] W. Q. Chen, H. Jin, M. Nguyen e al., “Role o au ine in egula ion o in acellula calcium le el and neu op o ec i e unc ion in cul u ed neu ons,” Jou nal o Neu oscience Resea ch, ol.66,no.4,pp.612–619,2001. [13] J.-Y.Wu,W.Chen,X.W.Tange al.,“Modeo ac iono au ine and egula ion dynamics o i s syn hesis in he CNS,” Ad ances in Expe imen al Medicine and Biology, ol.483,pp.35–44,2000. [14] H. Wu, Y. Jin, J. Wei, H. Jin, D. Sha, and J.-Y. Wu, “Mode o ac ion o au ine as a neu op o ec o ,” B ain Resea ch, ol.1038,no.2, pp. 123–131, 2005. [15] A. El Id issi and E. T enkne , “Tau ine egula es mi ochond ial calcium homeos asis,” Ad ances in Expe imen al Medicine and Biology, ol.526,pp.527–536,2003. [16] E. D. F ench, A. Vezzani, W. O. Whe sell J ., and R. Schwa cz, “An i-exci o oxic ac ions o au ine in he a hippocampus s udied in i o and in i o,” Ad ances in Expe imen al Medicine and Biology, ol.203,pp.349–362,1986. [17] P. Sa ansaa i and S. S. Oja, “Enhanced au ine elease in cell- damaging condi ions in he de eloping and ageing mouse hippocampus,” Neu oscience, ol.79,no.3,pp.847–854,1997. [18] P.Sa ansaa iandS.S.Oja,“Releaseo endogenousglu ama e, aspa a e, GABA, and au ine om hippocampal slices om adul and de eloping mice unde cell-damaging condi ions,” Neu ochemical Resea ch, ol. 23, no. 4, pp. 563–570, 1998. [19] P.Kon oandS.S.Oja,“Tau ineandGABA elease ommouse ce eb al co ex slices: po assium s imula ion eleases mo e au ine han GABA om de eloping b ain,” De elopmen al B ain Resea ch, ol.37,no.1-2,pp.277–291,1987. [20] G. Le i, “Release o pu a i e ansmi e amino acids,” in Handbook o Neu ochemis y, A. Laj ha, Ed., ol. 6, pp. 463–509, Plenum P ess, New Yo k, NY, USA, 2nd edi ion, 1984. [21] P. Sa ansaa i and S. S. Oja, “Release o GABA and au ine om b ain slices,” P og ess in Neu obiology, ol.38,no.5,pp.455– 482, 1992. [22] S. S. Oja and P. Sa ansaa i, “Tau ine,” in Handbook o Neu o- chemis y and Molecula Neu obiology,S.S.Oja,P.Sa ansaa i, and A. Schousboe, Eds., ol. 6, pp. 155–206, Sp inge , New Yo k, NY, USA, 3 d edi ion, 2007. [23] A.Schousboe,J.Mo ´ an, and H. Pasan es-Mo ales, “Po assium- s imula ed elease o au ine om cul u ed ce ebella g anule neu ons is associa ed wi h cell swelling,” Jou nal o Neu oscience Resea ch, ol.27,no.1,pp.71–77,1990. [24] H. K. Kimelbe g, N. B. Nes o , and P. J. Feus el, “Inhibi ion o elease o au ine and exci a o y amino acids in ischemia and neu op o ec ion,” Neu ochemical Resea ch, ol.29,no.1,pp. 267–274, 2004. [25] H. Pasan es-Mo ales, S. Ala ez, R. S. Olea, and J. Mo ´ an, “Con ibu ion o o ganic and ino ganic osmoly es o olume egula ion in a b ain cells in cul u e,” Neu ochemical Resea ch, ol.18,no.4,pp.445–452,1993. [26] P. J. Feus el, Y. Jin, and H. K. Kimelbe g, “Volume- egula ed anion channels a e he p edominan con ibu o s o elease o exci a o y amino acids in he ischemic co ical penumb a,” S oke, ol.35,no.5,pp.1164–1168,2004. Jou nal o Amino Acids 7 [27] R. S´ anchez-Olea, C. Pe˜ na, J. Mo ´ an, and H. Pasan es-Mo ales, “Inhibi ion o olume egula ion and e lux o osmo egula o y amino acids by blocke s o Cl− anspo in cul u ed as ocy es,” Neu oscience Le e s, ol.156,no.1-2,pp.141–144,1993. [28] T. Smi no a, J. S innak e, and J. Malle , “Cha ac e iza ion o a p esynap ic glu ama e ecep o ,” Science, ol.262,no.5132,pp. 430–433, 1993. [29] S. S. Oja and P. Sa ansaa i, “Modula ion o au ine elease in glucose- ee media by glu ama e ecep o s in hippocampal slices om de eloping and adul mice,” Amino Acids, ol.44, no. 2, pp. 533–542, 2013. [30]R.N.Icho d,M.V.Johns on,andR.J.T ays man,“MK801 dec eases glu ama e elease and oxida i e me abolism du ing hypoglycemic coma in pigle s,” De elopmen al B ain Resea ch, ol. 128, no. 2, pp. 139–148, 2001. [31] D. S. B ed , C. D. Fe is, and S. H. Snyde , “Ni ic oxide syn hase egula o y si es. Phospho yla ion by cyclic AMP-dependen p o ein kinase, p o ein kinase C, and calcium/calmodulin p o ein kinase; iden i ica ion o la in and calmodulin binding si es,” TheJou nalo BiologicalChemis y, ol.267,no.16,pp. 10976–10981, 1992. [32] E. M. Schuman and D. V. Madison, “Ni ic oxide and synap ic unc ion,” Annual Re iew o Neu oscience, ol.17,pp.153–183, 1994. [33] P. Sa ansaa i and S. S. Oja, “Tau ine elease in he de eloping and adul mouse hippocampus: in ol emen o cyclic guanosine monophospha e,” Neu ochemical Resea ch, ol.27,no.1-2,pp. 15–20, 2002. [34] V. M. Bolo ina, S. Najibi, J. J. Palacino, P. J. Pagano, and R. A. Cohen, “Ni ic oxide di ec ly ac i a es calcium-dependen po assiumchannelsin ascula smoo hmuscle,”Na u e, ol. 368, no. 6474, pp. 850–853, 1994. [35] L. R. Zhong, S. Es es, L. A inian, and V. Rehde , “Ni ic oxide egula es neu onal ac i i y ia calcium-ac i a ed po assium channels,” PLoS ONE, ol. 8, no. 11, A icle ID e78727, 2013. [36]Y.Kang,Y.Dempo,A.Ohashie al.,“Ni icoxideac i a es leak K+cu en s in he p esumed choline gic neu on o basal o eb ain,” Jou nal o Neu ophysiology, ol. 98, no. 6, pp. 3397– 3410, 2007. [37] Z.Li,M.W.Chapleau,J.N.Ba es,K.Biele eld ,H.-C.Lee,andF. M. Abboud, “Ni ic oxide as an au oc ine egula o o sodium cu en s in ba o ecep o neu ons,” Neu on, ol.20,no.5,pp. 1039–1049, 1998. [38] M. Rengana han, T. R. Cummins, and S. G. Waxman, “Ni ic oxide blocks as , slow, and pe sis en Na+channels in C- ype DRG neu ons by S-ni osyla ion,” Jou nalo Neu ophysiology, ol.87,no.2,pp.761–775,2002. [39] A. K. M. Hamma s om and P. W. Gage, “Ni ic oxide inc eases pe sis en sodium cu en in a hippocampal neu ons,” Jou nal o Physiology, ol.520,pa 2,pp.451–461,1999. [40] X. Han, A. B. Pa e s, D. P. Jones, I. Zeliko ic, and R. W. Chesney, “The au ine anspo e : mechanisms o egula ion,” Ac a Physiologica, ol.187,no.1-2,pp.61–73,2006. [41] H. K. Kimelbe g, S. K. Gode ie, S. Higman, S. Pang, and R. A. Waniewski, “Swelling-induced elease o glu ama e, aspa a e, and au ine om as ocy e cul u es,” The Jou nal o Neu o- science, ol.10,no.5,pp.1583–1591,1990. [42] A. Schousboe, R. Sanchez-Olea, J. Mo ´ an, and H. Pasan es- Mo ales, “Hyposmola i y-induced au ine elease in ce ebella g anule cells is associa ed wi h di usion and no wi h high- a ini y anspo ,” Jou nal o Neu oscience Resea ch, ol.30,no. 4, pp. 661–665, 1991. [43] S. Fa he azi, K. T. Izu su, R. B. Wellne , and C. M. Bel on, “Hypo onically ac i a ed chlo ide cu en in HSG cells,” Jou nal o Memb ane Biology, ol.142,no.2,pp.181–193,1994. [44] P. Sa ansaa i and S. S. Oja, “In ol emen o me abo opic glu- ama e ecep o s in au ine elease in he adul and de eloping mouse hippocampus,” Amino Acids, ol.16,no.2,pp.165–179, 1999. [45] R. A. Cunha, “Adenosine as a neu omodula o and as a homeo- s a ic egula o in he ne ous sys em: di e en oles, di e en sou ces and di e en ecep o s,” Neu ochemis y In e na ional, ol.38,no.2,pp.107–125,2001. [46] P.Sa ansaa iandS.S.Oja,“In e ac ionso au ineandadeno- sine in he mouse hippocampus in no moxia and ischemia,” Ad ances in Expe imen al Medicine and Biology, ol.526,pp. 445–451, 2003. Submi you manusc ip s a h p://www.hindawi.com Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Ana omy Resea ch In e na ional Pep ides In e na ional Jou nal o Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Hindawi Publishing Co po a ion h p://www.hindawi.com In e na ional Jou nal o Volume 2014 Zoology Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Molecula Biology In e na ional Genomics In e na ional Jou nal o Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 The Scien i ic Wo ld Jou nal Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Bioin o ma ics Ad ances in Ma ine Biology Jou nal o Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Signal T ansduc ion Jou nal o Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 BioMed Resea ch In e na ional E olu iona y Biology In e na ional Jou nal o Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Biochemis y Resea ch In e na ional A chaea Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Gene ics Resea ch In e na ional Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Ad ances in Vi ology Hindawi Publishing Co po a ion h p://www.hindawi.com Nucleic Acids Jou nal o Volume 2014 S em Cells In e na ional Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 Enzyme Resea ch Hindawi Publishing Co po a ion h p://www.hindawi.com Volume 2014 In e na ional Jou nal o Mic obiology